What does positron emission tomography offer oncology?
- 31 October 2000
- journal article
- review article
- Published by Elsevier BV in European Journal Of Cancer
- Vol. 36 (16), 2028-2035
- https://doi.org/10.1016/s0959-8049(00)00292-6
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Modulation of fluorouracil tissue pharmacokinetics by eniluracil: in-vivo imaging of drug actionThe Lancet, 2000
- Positron emission tomography (PET) in diagnostic oncology: is it a necessary tool today?European Journal Of Cancer, 2000
- The value of positron emission tomography scanning in the detection of subclinical metastatic melanomaJournal of the American Academy of Dermatology, 2000
- Clinical assessment of positron emission tomography for the diagnosis of local recurrence in colorectal cancerBritish Journal of Surgery, 1999
- Positron Emission Tomography and Radioimmunotargeting: Aspects of Quantification and DosimetryActa Oncologica, 1999
- Staging of the Axilla in Breast CancerAnnals of Surgery, 1998
- 18F-labeled fluorouracil positron emission tomography and the prognoses of colorectal carcinoma patients with metastases to the liver treated with 5-fluorouracilCancer, 1998
- Early Prediction of Treatment Outcome in Head and Neck Cancer with 2-18FDG PETActa Oncologica, 1997
- Imaging, biodistribution and therapy potential of Halogenated tamoxifen analoguesLife Sciences, 1994
- Energies of Cosmic-Ray ParticlesPhysical Review B, 1932